孤立性脑转移非小细胞肺癌患者的临床决策探讨

既往认为孤立性脑转移非小细胞肺癌（NSCLC ）患者属于Ⅳ期，一般不考虑手术治疗，仅给予化疗或放疗等治疗，但很难达到理想的疗效。近年来通过多学科协作体系（MDT ）给予规范化、个体化治疗，使患者的获益程度明显增加，甚至可以达到治愈。现介绍2 例天津医科大学肿瘤医院多学科协作治疗孤立性脑转移NSCLC 患者的病例，以期探讨和制定相应诊疗规范，让更多的患者受益。

Clinical decision on solitary brain metastasis in patients with nonsmall cell lung cancer

Solitary brain metastasis in non-small cell lung cancer (NSCLC) patients was previously considered as Stage IV. Gen -erally, only chemotherapy or radiotherapy rather than surgery was considered the treatment for these patients; hence, achieving the de-sired effect was difficult. In recent years, the treatment benefit for these patients significantly increased. Several patients were even pro-vided the chance of being cured through standardized and individualized treatment by a multiple disciplinary team (MDT). This article introduces two solitary brain metastasis patients with NSCLC who were treated by MDT in Tianjin Medical University Cancer Institute and Hospital. This article aims to explore a complete set of diagnostic and treatment practices for the benefit of more patients.